Revvity Inc (RVTY)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account

Sell

$98.12

Buy

$102.84

arrow-down$-3.43 (-3.30%)

Prices updated at 12 Dec 2025, 22:11 EST

Prices minimum 15 mins delay

Prices in USD

PerkinElmer Inc is a diagnostics company that provides instruments, consumables, and services to biomedical, chemical and to general industrial markets. It operates in two segments namely Discovery and Analytical Solutions and Diagnostics.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Mr. Alexis P. Michas

CEO

Dr. Prahlad R. Singh, PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

11,000

Head office

77 4th Avenue

Waltham

United States

02451

+1 781 663-6900

-

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Anita Gonzales Vice President and Chief Accounting Officer	-
Mr. Alexis P. Michas Non-Executive Chairman of the Board	0.18m
Mr. Joel S. Goldberg Senior Vice President, Administration, General Counsel and Secretary	0.55m
Dr. Peter Barrett,PhD Independent Director	0.11m
Mr. Tajinder Vohra Senior Vice President, Global Operations	0.48m
Dr. Sophie V. Vandebroek, PhD Independent Director	0.08m
Dr. Frank R. Witney,, PhD Independent Director	0.09m
Ms. Pascale Witz, M. Sc.,M.B.A. Independent Director	0.09m
Mr. Michel Pericles Vounatsos Independent Director	0.11m
Dr. Prahlad R. Singh, PhD Director, President and Chief Executive Officer	1.10m
Mr. Samuel R. Chapin Independent Director	0.12m
Ms. Miriame Victor Senior Vice President and Chief Commercial Officer	0.47m
Mr. Michael A Klobuchar Independent Director	0.08m
Dr. Michelle McMurry-Heath, PhD Independent Director	0.09m
Mr. Maxwell Krakowiak Senior Vice President and Chief Financial Officer	0.51m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
T. Rowe Price Investment Management,Inc.	22,501,240
T. Rowe Price Capital Appreciation Fund	14,366,588
Vanguard Group Inc	14,088,798
Janus Capital Management LLC	11,249,128
BlackRock Inc	9,246,020

Director dealings

Date chevron-l-regular chevron-r-regular	Action
16 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
02 Dec 2024	-
09 Oct 2024	-
09 Oct 2024	-
07 Oct 2024	-
08 Oct 2024	-
08 Oct 2024	-
07 Oct 2024	-
16 Sep 2024	-
15 Aug 2024	-
07 Aug 2024	-
07 Aug 2024	-
07 Aug 2024	-
07 Aug 2024	-
17 Jun 2024	-
07 Jun 2024	-
07 Jun 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.